Primary prevention in hypertension. Valid conclusions from observational studies.

Area of Science:

• Cardiology
• Pharmacology
• Epidemiology

Background:

• Limited observational studies exist on antihypertensive drug therapy for primary prevention of coronary heart disease (CHD).
• Ensuring internal validity, particularly avoiding confounding by indication, is crucial for observational studies in this field.

Purpose of the Study:

• To review the role and challenges of observational studies in assessing antihypertensive drug efficacy for primary CHD prevention.
• To highlight the potential advantages and limitations of observational designs compared to randomized trials.

Main Methods:

• Review of existing observational studies (follow-up and case-control) on antihypertensive therapy and primary CHD prevention.
• Discussion of methodological considerations for ensuring internal validity and comparability in non-randomized studies.

Main Results:

• Few high-quality observational studies have been published on this topic.
• Preliminary findings suggest beta-blockers might provide superior protection against first CHD events compared to other antihypertensive regimens.

Conclusions:

• Observational studies can contribute valuable insights into antihypertensive therapy for primary CHD prevention.
• Appreciating the inherent potentials and pitfalls of observational designs is key to their effective use in this research area.
• Further robust observational research is necessary to confirm the potential benefits of specific drug classes like beta-blockers.